Showing results (381-390 of 3,697) with videos related to

Sort By:
Pageof 370
International Journal of Clinical Oncology|January 16, 2023
Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning systemShota Miyoshi, Ikuno Nishibuchi, Yuji Murakami, et al.
International Journal of Clinical Oncology|January 17, 2023
Association between financial toxicity and health-related quality of life of patients with gynecologic cancerYusuke Kajimoto, Kazunori Honda, Shiro Suzuki, et al.
International Journal of Clinical Oncology|December 6, 2022
Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS-JAPAN studyYoichiro Tohi, Ryou Ishikawa, Takuma Kato, et al.
International Journal of Clinical Oncology|November 23, 2022
The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancerNicolò Bizzarri, Marco D'Indinosante, Claudia Marchetti, et al.
International Journal of Clinical Oncology|November 29, 2019
The efficacy and safety of the addition of olanzapine to ondansetron and dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapyVeerisa Vimolchalao, Siwat Sakdejayont, Ploytuangporn Wongchanapai, et al.
International Journal of Clinical Oncology|November 30, 2019
Preoperative lymphocyte-to-monocyte ratio predicts postoperative infectious complications after laparoscopic colorectal cancer surgeryTunyaporn Kamonvarapitak, Akihisa Matsuda, Satoshi Matsumoto, et al.
International Journal of Clinical Oncology|November 30, 2019
Predictive value of 18F-FDG PET/CT for acute exacerbation of interstitial lung disease in patients with lung cancer and interstitial lung disease treated with chemotherapyKimitaka Akaike, Koichi Saruwatari, Seitaro Oda, et al.
International Journal of Clinical Oncology|November 14, 2019
Expression of PBRM1 as a prognostic predictor in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitorWen Cai, Zaoyu Wang, Biao Cai, et al.
International Journal of Clinical Oncology|November 16, 2019
Pembrolizumab versus chemotherapy in recurrent, advanced urothelial cancer in Japanese patients: a subgroup analysis of the phase 3 KEYNOTE-045 trialHiroyuki Nishiyama, Yoshiaki Yamamoto, Naoto Sassa, et al.
Pageof 370